An ‘energy support’ supplement is being recalled because it contains an undeclared medication used to treat erectile dysfunction.
Virginia-based Akkarco LLC is voluntarily recalling Ashfiat Alharamain Energy Support because of contamination with Tadalafil, an ingredient in FDA-approved products for erectile dysfunction.
The recall applies to the product sold in a glass bottle with an orange label. The universal product code is 1234561870003; the batch number is ENCOT24; and the expiration date is October 2028.
According to the FDA, products containing Tadalafil cannot be marketed as supplements, which are not overseen or regulated by any agency in the US.
Tadalafil is the active drug ingredient in the erectile dysfunction medication Cialis. It belongs to a class of drugs known as phosphodiesterase type‑5 (PDE‑5) inhibitors and can only be used under medical supervision.
Meanwhile, Ashfiat Alharamain Energy Support is an unapproved new drug. The FDA said safety and efficacy of the substance has not yet been established.
The supplement is available to buy and ship nationwide on Amazon and the company’s website.
The recall notice stated that people, especially those with underlying medical conditions, using Tadalafil without proper prescription and supervision may experience heart and blood pressure problems, dizziness and headaches.
The recall applies to the product sold in a glass bottle with an orange label. The universal product code is 1234561870003; the batch number is ENCOT24; and the expiration date is October 2028
To date, no adverse health events have been reported to the company in connection to the recall.
Customers who have purchased the product are being urged to stop using it immediately and dispose of it or return it to the place of purchase.
The recall was initiated after the FDA sampled the Akkarco product and testing revealed the presence of Tadalafil.
The FDA does not regulate dietary supplements to the same extent that prescription drugs are, with the agency only stepping in to issue warnings and recalls after a problem has been reported.
While it is FDA-approved, taking Tadalafil carries notable side effect risks, including headache, indigestion, back pain, muscle aches and dizziness.
Taking Tadalafil can also be dangerous for the millions of Americans taking medication to treat chest pain, such as nitroglycerin. Combining them can result in a critical drop in blood pressure.
This can cause dizziness, fainting, falls, heart attack or stroke due to the brain and heart not receiving enough blood flow.
Since men with diabetes, high blood pressure or heart disease are frequently prescribed nitrates, they face the most significant risk from these contaminated products.
A similar recall was issued in December.
StuffbyNainax LLC voluntarily recalled all lots of MR.7 SUPER 700000 capsules, sold as a dietary supplement, after testing showed the product contained Tadalafil, as well as Sildenafil, sold as Viagra and Revatio.
MR.7 SUPER 700000 capsules, marketed as a ‘male enhancement’ product, was distributed nationwide ‘to a limited number of online customers between August 2025 and November 2025,’ according to the FDA.
That recall did not say what led StuffbyNainax LLC to initiate the recall or whether it learned of the undeclared ingredients from a consumer or outside lab.
